Results 51 to 60 of about 41,209 (140)

Passive Immunization

Citation: 'passive immunization' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.13540 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms ...
  +5 more sources

Real-world data and clinical management experience in passive immunization for respiratory syncytial virus prevention in children

Vaccine: X
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections in children under 5 years of age worldwide. Currently, there are no approved curative treatments, and clinical management remains primarily focused on ...
Yongping Xie, Xin Cong, Yan Li, Lisu Huang   +3 more
doaj   +1 more source

A real-world based study for immunogenicity and safety for three immunization schedules of polio vaccine

Scientific Reports
To evaluate the immunogencity and safety for three immunization schedules of inactivated poliovirus vaccine (IPV) and bivalent oral poliovirus vaccine (bOPV) for providing a basis for further optimization of the polio sequential immunization schedule. To
Li Sun, Shi-fan Wang, Yi-qing Zhu, Ya-fei Wang, Jun-mian Zhang, Jing-hui Wang, Yan-li Cong, Jing Li, Xiao-qin Liu, Sha-sha Han, Yu Guo, Qi Li   +11 more
doaj   +1 more source

Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence

Journal of Neuroinflammation, 2011
Background Anti-Aβ immunotherapy is a promising approach to the prevention and treatment of Alzheimer's disease (AD) currently in clinical trials. There is extensive evidence, both in mice and humans that a significant adverse event is the occurrence of ...
Ridnour Lisa A, Taylor Tiffany L, Gordon Marcia N, Morgan Dave, Wilcock Donna M, Wink David A, Colton Carol A   +6 more
doaj   +1 more source

Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities

Emerging Microbes and Infections, 2019
Because of its high infectivity in humans and the lack of effective vaccines, Nipah virus is classified as a category C agent and handling has to be performed under biosafety level 4 conditions in non-endemic countries, which has hindered the development
Jianhui Nie, Lin Liu, Qing Wang, Ruifeng Chen, Tingting Ning, Qiang Liu, Weijin Huang, Youchun Wang   +7 more
doaj   +1 more source

Review and Update of Active and Passive Immunization Against Respiratory Syncytial Virus. [PDF]

BioDrugs, 2023
Verwey C, Madhi SA.
europepmc   +1 more source

Immunization strategies against respiratory syncytial virus in Panama: considerations for decision-making in a tropical country—a working group meeting report

Frontiers in Public Health
Following the approval of the respiratory syncytial virus (RSV) vaccine and a new monoclonal antibody for passive immunization in children, some Latin American countries have begun using both strategies to prevent RSV-disease.
Xavier Sáez-Llorens, Catherine Lissette Castillo, Danilo Franco, Raúl Esquivel, Kathia Luciani, Rodrigo DeAntonio   +5 more
doaj   +1 more source

Current strategies and perspectives for active and passive immunization against Respiratory Syncytial Virus in childhood. [PDF]

J Pediatr (Rio J), 2023
Scotta MC, Stein RT.
europepmc   +1 more source

<i>In vitro</i> generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2. [PDF]

Antib Ther, 2023
Buzas D, Bunzel AH, Staufer O, Milodowski EJ, Edmunds GL, Bufton JC, Vidana Mateo BV, Yadav SKN, Gupta K, Fletcher C, Williamson MK, Harrison A, Borucu U, Capin J, Francis O, Balchin G, Hall S, Vega MV, Durbesson F, Lingappa S, Vincentelli R, Roe J, Wooldridge L, Burt R, Anderson RJL, Mulholland AJ, Bristol Uncover Group, Hare J, Bailey M, Davidson AD, Finn A, Morgan D, Mann J, Spatz J, Garzoni F, Schaffitzel C, Berger I.   +36 more
europepmc   +1 more source

Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine. [PDF]

Vaccines (Basel), 2022
Haile CN, Varner KJ, Huijing X, Arora R, Orson FM, Kosten TR, Kosten TA.   +6 more
europepmc   +1 more source